PLAY PODCASTS
Biotechnology is a National Security Asset
Episode 87

Biotechnology is a National Security Asset

Since Watson and Crick discovered DNA's double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the world. In this episode, we talk about why this leadership position may be threatened and why that matters to our national security.

I AM BIO · Vic Suarez Founder Blu Zone Bio Colonel US Army (Retired), Monique Mansoura PhD MBA Executive Director Global Health Security & Biotechnology MITRE, Jason Kelly PhD Co-Founder and CEO Ginkgo Bioworks

September 24, 202427m 14s

Audio is streamed directly from the publisher (chtbl.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Since Watson and Crick discovered DNA's double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the world. In this episode, we talk about why this leadership position may be threatened and why that matters to our national security.

Follow us on LinkedIn, X, Facebook and Instagram

Visit us at https://www.bio.org/

Topics

ebolavaccinessemiconductorschinabiomanufacturingdomestic industrial basepandemiccovidgeopolitical threatsbiotechnologysupply chainu.s. leadershipbiosecure actbreakthroughscritical materialsanthraxmitigating riskvulnerabilitiesrobust biotech sectorpharmaceutical industrial basenational securityresilient supply chainbioindustrial baseaipublic healthdatascale upsupply chain disruptionsbiodefenseindependencenation’s safetychronic drug shortagesresilient bio industrial basecrisisdefense industrial basesustainabilitypreparednessdependence